Grabovac Igor, Brath Helmut, Schalk Horst, Degen Olaf, Dorner Thomas E
Department of Social and Preventive Medicine, Centre for Public Health, Medical University of Vienna, Kinderspitalgasse 15/1, 1090, Vienna, Austria.
Health Centre South, Wienerbergstrasse 13, 1100, Vienna, Austria.
Qual Life Res. 2017 Sep;26(9):2387-2395. doi: 10.1007/s11136-017-1580-y. Epub 2017 Apr 20.
To report on the global quality of life (QOL) in people living with HIV (PLWHIV) and how a smoking cessation intervention influences the changes in QOL.
Participants were asked to fill out a questionnaire during visits to their HIV outpatient clinic consisting of sociodemographic information, general health data and the WHOQOL HIV-Bref. Exhaled carbon monoxide measurements were used to confirm the smoking status, based on which participants classified as smokers received a short 5 min structured intervention and were offered participation in a full smoking cessation programme consisting of five sessions. Follow-up was done 8 months after the baseline.
Overall 447 (mean age = 45.5) participants took part with 221 being classified as smokers. A total of 165 (74.6%) participants received a short intervention and 63 (29.4%) agreed to participate in the full program. At baseline, differences in QoL were observed, where smokers had lower QoL in domains of physical (M = 16.1 vs. 15.3, p = 0.009) and psychological (M = 15.3 vs. 14.6, p = 0.021) well-being, independency level (M = 16.1 vs. 15.2, p = 0.003) and environment (M = 16.5 vs. 16.0, p = 0.036). At study end, 27 (12.2%) participants quit smoking; 12 (19.0%) participants of the full programme and 15 (14.7%) that received the short intervention. There were no significant differences in QoL between those that continued to smoke and quitters at follow-up.
Quality of life results may be used to better understand the underlying motivation of PLWHIV who start cessation programs. In order to reduce the high prevalence and health burden that smoking causes in PLWHIV, it is necessary to introduce effective interventions that can be used in the clinical settings.
报告全球范围内人类免疫缺陷病毒感染者(PLWHIV)的生活质量(QOL),以及戒烟干预如何影响生活质量的变化。
参与者在前往其艾滋病门诊就诊时被要求填写一份问卷,内容包括社会人口统计学信息、一般健康数据以及世界卫生组织生活质量HIV简表(WHOQOL HIV-Bref)。通过呼出一氧化碳测量来确认吸烟状况,据此将被归类为吸烟者的参与者给予5分钟的简短结构化干预,并提供参与由五个环节组成的完整戒烟计划的机会。在基线期8个月后进行随访。
共有447名(平均年龄 = 45.5岁)参与者,其中221人被归类为吸烟者。共有165名(74.6%)参与者接受了简短干预,63名(29.4%)同意参与完整计划。在基线期,观察到生活质量存在差异,吸烟者在身体(M = 16.1对15.3,p = 0.009)和心理(M = 15.3对14.6,p = 0.021)幸福感、独立水平(M = 16.1对15.2,p = 0.003)和环境(M = 16.5对16.0,p = 0.036)等领域的生活质量较低。在研究结束时,27名(12.2%)参与者戒烟;完整计划组中有12名(19.0%)参与者,接受简短干预组中有15名(14.7%)参与者。随访时,继续吸烟者和戒烟者之间的生活质量没有显著差异。
生活质量结果可用于更好地理解开始戒烟计划的PLWHIV的潜在动机。为了降低吸烟在PLWHIV中造成的高流行率和健康负担,有必要引入可在临床环境中使用的有效干预措施。